Co-Diagnostics Inc (CODX)

$2.80 +0.17 (6.46%)
Market Cap 5.87M
Revenue (ttm) 3.92M
Net Income (ttm) -37.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -960.20%
Debt to Equity Ratio 0.00
Volume 1,105,300
Avg Vol 153,403
Day's Range N/A - N/A
Shares Out 2.10M
Stochastic %K 32%
Beta 1.31
Analysts Hold
Price Target $45.00

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus...

Industry: Medical Devices
Sector: Healthcare
Phone: 801 438 1036
Website: co-dx.com
Address:
2401 S. Foothill Dr., Suite D, Salt Lake City, United States
jplhd
jplhd Mar. 15 at 11:46 PM
$CODX hearing Clinicals have been less than stellar.. also Covid maybe dropped from FluA/B, Covid, RSV test and future 510k submission. This company isnt saving itself. #firesale
0 · Reply
Motorhhead
Motorhhead Mar. 15 at 6:53 PM
$MYNZ $MLEC $CODX $CXAI Thanks again for the short recommendations! This guy needs to be elected to the short trading hall of fame! https://stocktwits.com/beppels/message/647430437
1 · Reply
SmallPhish
SmallPhish Mar. 15 at 1:24 AM
$CODX Maybe Dwight should try another reverse split to move the share price higher
0 · Reply
Antiquarian
Antiquarian Mar. 14 at 11:12 AM
$CODX
0 · Reply
Antiquarian
Antiquarian Mar. 14 at 11:11 AM
$CODX Something is going to be released very soon.
1 · Reply
Minutiae
Minutiae Mar. 14 at 9:05 AM
$CODX CDC Respiratory Virus Activity Levels Mar. 13, 2026 For Everyone Provides an update on how COVID-19, influenza, and RSV may be spreading nationally and in your state. https://www.cdc.gov/respiratory-viruses/data/activity-levels.html
0 · Reply
Minutiae
Minutiae Mar. 14 at 9:04 AM
$CODX Mar 13 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Minutiae
Minutiae Mar. 14 at 9:03 AM
$CODX Mar 13 CODX volume 1,105,319 closing at $2.80 Chart starts shortly after 9:30 am to avoid volume being overwhelmed by premarket volume. 28,780 after-hour shares traded at $2.60 to $2.848. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
OvernightSwingKing
OvernightSwingKing Mar. 13 at 6:48 PM
$CODX added for swing
0 · Reply
_dailyBULLetin
_dailyBULLetin Mar. 13 at 6:21 PM
$VEEE $CODX $ASNS $SMX π
0 · Reply
Latest News on CODX
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Mar 12, 2026, 9:00 AM EDT - 3 days ago

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Mar 10, 2026, 9:00 AM EDT - 5 days ago

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Feb 9, 2026, 9:00 AM EST - 4 weeks ago

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Feb 5, 2026, 9:00 AM EST - 5 weeks ago

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Feb 4, 2026, 9:00 AM EST - 5 weeks ago

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Jan 12, 2026, 9:00 AM EST - 2 months ago

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Co-Diagnostics Announces Reverse Stock Split

Dec 30, 2025, 9:00 AM EST - 2 months ago

Co-Diagnostics Announces Reverse Stock Split

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Dec 29, 2025, 9:00 AM EST - 2 months ago

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Dec 18, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Dec 17, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Dec 9, 2025, 9:00 AM EST - 3 months ago

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Dec 8, 2025, 12:36 PM EST - 3 months ago

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Nov 20, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Nov 18, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Co-Diagnostics, Inc. (CODX) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 7:01 PM EST - 4 months ago

Co-Diagnostics, Inc. (CODX) Q3 2025 Earnings Call Transcript

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 4:01 PM EST - 4 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Co-Diagnostics, Inc. (CODX) Discusses Saudi Arabia Joint Venture, AI Initiatives and Diagnostics Technology Developments Transcript

Nov 5, 2025, 10:51 PM EST - 4 months ago

Co-Diagnostics, Inc. (CODX) Discusses Saudi Arabia Joint Venture, AI Initiatives and Diagnostics Technology Developments Transcript

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Nov 5, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Nov 3, 2025, 9:00 AM EST - 4 months ago

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Oct 31, 2025, 9:00 AM EDT - 4 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Oct 30, 2025, 1:57 PM EDT - 4 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 29, 2025, 12:51 PM EDT - 4 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 28, 2025, 9:33 AM EDT - 4 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Oct 22, 2025, 8:30 AM EDT - 5 months ago

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Oct 16, 2025, 9:30 AM EDT - 5 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Oct 13, 2025, 9:30 AM EDT - 5 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Sep 30, 2025, 9:30 AM EDT - 5 months ago

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 18, 2025, 5:05 PM EDT - 6 months ago

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 17, 2025, 9:47 AM EDT - 6 months ago

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Sep 11, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Sep 9, 2025, 9:30 AM EDT - 6 months ago

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Aug 18, 2025, 9:30 AM EDT - 7 months ago

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics, Inc. (CODX) Q2 2025 Earnings Conference Call Transcript

Aug 14, 2025, 7:42 PM EDT - 7 months ago

Co-Diagnostics, Inc. (CODX) Q2 2025 Earnings Conference Call Transcript

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 4:01 PM EDT - 7 months ago

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Jul 31, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

Jul 15, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

May 14, 2025, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:59 PM EDT - 11 months ago

Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

May 8, 2025, 4:01 PM EDT - 11 months ago

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Apr 29, 2025, 7:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast

Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 6:44 PM EDT - 1 year ago

Co-Diagnostics, Inc. (CODX) Q4 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Mar 27, 2025, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Mar 13, 2025, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Mar 3, 2025, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Feb 24, 2025, 8:18 AM EST - 1 year ago

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

Feb 21, 2025, 4:00 PM EST - 1 year ago

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

Jan 7, 2025, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

Dec 10, 2024, 9:30 AM EST - 1 year ago

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 8:49 PM EST - 1 year ago

Co-Diagnostics, Inc. (CODX) Q3 2024 Earnings Call Transcript

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:01 PM EST - 1 year ago

Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results

jplhd
jplhd Mar. 15 at 11:46 PM
$CODX hearing Clinicals have been less than stellar.. also Covid maybe dropped from FluA/B, Covid, RSV test and future 510k submission. This company isnt saving itself. #firesale
0 · Reply
Motorhhead
Motorhhead Mar. 15 at 6:53 PM
$MYNZ $MLEC $CODX $CXAI Thanks again for the short recommendations! This guy needs to be elected to the short trading hall of fame! https://stocktwits.com/beppels/message/647430437
1 · Reply
SmallPhish
SmallPhish Mar. 15 at 1:24 AM
$CODX Maybe Dwight should try another reverse split to move the share price higher
0 · Reply
Antiquarian
Antiquarian Mar. 14 at 11:12 AM
$CODX
0 · Reply
Antiquarian
Antiquarian Mar. 14 at 11:11 AM
$CODX Something is going to be released very soon.
1 · Reply
Minutiae
Minutiae Mar. 14 at 9:05 AM
$CODX CDC Respiratory Virus Activity Levels Mar. 13, 2026 For Everyone Provides an update on how COVID-19, influenza, and RSV may be spreading nationally and in your state. https://www.cdc.gov/respiratory-viruses/data/activity-levels.html
0 · Reply
Minutiae
Minutiae Mar. 14 at 9:04 AM
$CODX Mar 13 Full day chart. https://www.nasdaq.com/market-activity/stocks/codx
0 · Reply
Minutiae
Minutiae Mar. 14 at 9:03 AM
$CODX Mar 13 CODX volume 1,105,319 closing at $2.80 Chart starts shortly after 9:30 am to avoid volume being overwhelmed by premarket volume. 28,780 after-hour shares traded at $2.60 to $2.848. https://www.nasdaq.com/market-activity/stocks/codx/advanced-charting
0 · Reply
OvernightSwingKing
OvernightSwingKing Mar. 13 at 6:48 PM
$CODX added for swing
0 · Reply
_dailyBULLetin
_dailyBULLetin Mar. 13 at 6:21 PM
$VEEE $CODX $ASNS $SMX π
0 · Reply
DineroSci
DineroSci Mar. 13 at 5:46 PM
$CODX looking for some nice power hour and ah action here
0 · Reply
Antiquarian
Antiquarian Mar. 13 at 4:07 PM
$CODX
0 · Reply
DineroSci
DineroSci Mar. 13 at 3:50 PM
$CODX almost
0 · Reply
FonsieTrader
FonsieTrader Mar. 13 at 3:42 PM
$CODX for next week
0 · Reply
coolmate25
coolmate25 Mar. 13 at 3:16 PM
$CODX This sh-t supposed to be at least $10 . Anything less than that is a super B.S .
0 · Reply
SmallPhish
SmallPhish Mar. 13 at 2:58 PM
$CODX COVID Play
0 · Reply
DineroSci
DineroSci Mar. 13 at 2:27 PM
$CODX 👀
0 · Reply
StockTone
StockTone Mar. 13 at 1:24 PM
$CODX Easy Money... 👌💪👍💎
0 · Reply
TheOpticZone
TheOpticZone Mar. 13 at 1:22 PM
$CODX Don't get it. Runs to $4 AH and then right back down to no gain.
0 · Reply
coolmate25
coolmate25 Mar. 13 at 12:31 PM
$CODX low life institutional criminals and some filthy goones fkin this stock up by pumping and dumping. Fck their pathetic life.
0 · Reply
sweet_Journey
sweet_Journey Mar. 13 at 10:14 AM
$CXAI $CODX $EONR
0 · Reply
BaridBanger
BaridBanger Mar. 13 at 9:45 AM
$CODX got some
0 · Reply